nach oben

Erschienen in:

15.12.2017 | Case Based Review

Eosinophilic fasciitis during pregnancy: case report and review of literature

verfasst von: Maria Ester Simeira Fonseca, Maria Victória Quaresma, Ana Paula Luppino-Assad, Henrique Carriço da Silva, Danieli Castro O. Andrade, Percival D. Sampaio-Barros

Erschienen in: Rheumatology International | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

The authors describe the case of a 23-year-old woman who was referred to the rheumatologist due to symmetrical and progressive stiffness, induration, and swelling of arms and thighs at the 12th week of her first gestation. The characteristic clinical aspect of ‘peau d’orange’, associated to the histopathologic results of the deep biopsy of the skin confirmed the diagnosis of eosinophilic fasciitis. Treatment with oral prednisone, at an initial dose of 1 mg/kg/day, was effective and rapidly tapered to 10 mg/day till the birth of a healthy newborn. A literature review showed only one previous description of pregnancy and eosinophilic fasciitis.

Shulman LE (1974) Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? (abstr). J Rheumatol 1(Suppl):46

Rodnan GP, DiBartolomeo AG, Medsger TA Jr, Barnes EL Jr (1975) Eosinophilic fasciitis: Report of 7 cases of a newly recognized scleroderma-like syndrome (abstr). Arthritis Rheum 18:122–423CrossRef

Daniel RS, Lavery S, Maize JC Jr, Brown AN, Bolster MB (2009) Unilateral eosinophilic fasciitis: an under-recognized subtype? J Clin Rheumatol 15:247–249CrossRefPubMed

Pinal-Fernandez I, Selva-O’ Callaghan A, Grau JM (2014) Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev 13:379–382CrossRefPubMed

Granter SR, Barnhill RL, Duray PH (1996) Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol 18:465–473CrossRefPubMed

Hashimoto Y, Takahashi H, Matsuo S et al (1996) Polymerase chain reaction of Borrelia burgdorferi flagellin gene in Shulman syndrome. Dermatology 192:136–139CrossRefPubMed

Sillo P, Pinter D, Ostorhazi E et al (2012) Eosinophilic Fasciitis associated with Mycoplasma arginini infection. J Clin Microbiol 50:1113–1117CrossRefPubMedPubMedCentral

Hayashi N, Igarashi A, Matsuyama T, Harada S (2000) Eosinophilic fasciitis following exposure to trichloroethylene: successful treatment with cyclosporin. Br J Dermatol 142:830–832CrossRefPubMed

Choquet-Kastylevsky G, Kanitakis J, Dumas V, Descotes J, Faure M, Claudy A (2001) Eosinophilic fasciitis and simvastatin. Arch Inter Med 161:1456–1457CrossRef

10.

DeGiovanni C, Chard M, Woollons A (2006) Eosinophilic fasciitis secondary to treatment with atorvastatin. Clin Exp Dermatol 31:131–132CrossRefPubMed

11.

Buchanan RR, Gordon DA, Muckle TJ, McKenna F, Kraag G (1980) The eosinophilic fasciitis syndrome after phenytoin (dilantin) therapy. J Rheumatol 7:733–736PubMed

12.

Serratrice J, Pellissier JF, Champsaur P, Weiller PJ (2007) Fasciitis with eosinophilia: a possible causal role of angiotensin converting enzyme inhibitor. Rev Neurol (Paris) 163:241–243CrossRef

13.

Cantini F, Salvarani C, Olivieri I et al (1998) Possible association between eosinophilic fasciitis and subcutaneous heparin use. J Rheumatol 25:383–385PubMed

14.

Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB (1988) Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17:221–231CrossRefPubMed

15.

Endo Y, Tamura A, Matsushima Y et al (2007) Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome. Clin Rheumatol 26:1445–1451CrossRefPubMed

16.

Lebeaux D, Frances C, Barete S et al (2012) Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology 51:557–561CrossRefPubMed

17.

Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA (2016) Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers. JAMA Dermatol 152:97–99CrossRefPubMed

18.

Mertens JS, Thurlings RM, Kievit W, Seyger MMB, Radstake TRD, de Jong EMGJ. (2017) Long-term outcome of eosinophilic fasciitis: a cross-sectional evaluation of 35 patients. J Am Acad Dermatol 77:512–517CrossRefPubMed

19.

Papa R, Nozza P, Granata C et al (2016) Juvenile eosinophilic fasciitis: three case reports with review of the literature. Clin Exp Rheumatol 34:527–530PubMed

20.

Bischoff L, Derk CT (2008) Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol 47:29–35CrossRefPubMed

21.

Amdur HS, Levin RE (1989) Eosinophilic fasciitis during pregnancy. Obstet Gynecol 73(5 Pt 2):843–847PubMed

22.

Strosberg JM (1979) Eosinophilic fasciitis following pregnancy. JAMA 241(20):2144CrossRefPubMed

23.

Onajin O, Wieland CN, Peters M, Lohse CM, Lehman JS (2017) Clinicopathologic and immunophenotypic features of eosinophilic fasciitis and morphea profunda: a comparative study of 27 cases. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2017.06.148

24.

Lebaux D, Sène D (2012) Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol 26:449–458CrossRef

25.

Fujimoto M, Sato S, Ihn H, Kikuchi K, Yamada N, Takehara K (1995) Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis. J Rheumatol 22:563–565PubMed

26.

Kirchgesner T, Dallaudiere B, Omoumi P et al (2015) Eosinophilic fasciitis: typical abnormalities, variants and differential diagnosis of fasciae abnormalities using MRI imaging. Diagn Interv Imaging 96:341–348CrossRefPubMed

27.

Mazori DR, Femia AN, Vleugels RA (2017) Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep 19:74CrossRefPubMed

28.

Caspi D, Fishel R, Varon M, Yona E, Baratz M, Yaron M (1982) Multisystem presentation of eosinophilic fasciitis. Rheumatol Rehab 21:218–221CrossRef

29.

De Jonge-Bok JM, Steven MM, Eulderink F, Cats A (1984) Diffuse (eosinophilic) fasciitis. A series of six cases. Clin Rheumatol 3:365–373CrossRefPubMed

30.

Chaudhary UB, Eberwine SF, Hege KM (2004) Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis: a long relapsing and remitting course. Am J Hematol 75:146–150CrossRefPubMed

31.

Bukiej A, Dropinski J, Dyduch G, Szczeklik (2005) Eosinophilic fasciitis successfully treated with cyclosporine. Clin Rheumatol 24:634–636CrossRefPubMed

32.

Smith LC, Cox NH (2008) Dapsone treatment for eosinophilic fasciitis. Arch Dermatol 144:845–847CrossRefPubMed

33.

Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA (2003) Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 7:382–386CrossRefPubMed

34.

Haiduc VF, Erkan D, Kirou K, Birchansky S, Park J, Danon MJ (2008) Anti-neutrophil cytoplasmic antibody (c-ANCA) positive recurrent eosinophilic fasciitis responsive to cyclophosphamide: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. Hosp Spec Surg J 4:81–86

35.

Khanna D, Agrawal H, Clements PJ (2010) Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases. Rheumatology 49:1184–1188CrossRefPubMedPubMedCentral

36.

Scheinberg M, Hamerschlak N, Kutner JM et al (2006) Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002–2004). Clin Exp Rheumatol 24:65–69PubMed

Titel: Eosinophilic fasciitis during pregnancy: case report and review of literature
verfasst von: Maria Ester Simeira Fonseca
Maria Victória Quaresma
Ana Paula Luppino-Assad
Henrique Carriço da Silva
Danieli Castro O. Andrade
Percival D. Sampaio-Barros
Publikationsdatum: 15.12.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 3/2018
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-017-3908-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Eosinophilic fasciitis during pregnancy: case report and review of literature

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Demenzkranke durch Antipsychotika vielfach gefährdet

Drei Mythen bei der Antibiotikatherapie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology

Construct validity and sensitivity to change of Belgrade Ultrasound Enthesitis Score in patients with spondyloarthritis: a pilot study

Treatment of drug-resistant fibromyalgia symptoms using high-intensity laser therapy: a case-based review

Long-term efficacy of spa therapy in patients with rheumatoid arthritis

‘Exercise to me is a scary word’: perceptions of fatigue, sleep dysfunction, and exercise in people with fibromyalgia syndrome—a focus group study

Association of polymorphisms in TNF and GRN genes with ankylosing spondylitis in a Chinese Han population

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Demenzkranke durch Antipsychotika vielfach gefährdet

Drei Mythen bei der Antibiotikatherapie

Update Innere Medizin